AGCO and Bosch BASF Smart Farming Announce Joint Development and Commercialization of Smart Spraying Capabilities
6.4.2023 15:30:00 EEST | Business Wire | Press release
AGCO Corporation announced today that together with Bosch BASF Smart Farming it will integrate and commercialize Smart Spraying technology on Fendt Rogator sprayers, and jointly develop additional, new features.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230406005041/en/
Fendt Rogator 665 using the Smart Spraying Solution targeted spraying in a green-on-brown trial application. (Photo: Business Wire)
In May 2021, AGCO and Bosch BASF Smart Farming started the first trials of Bosch BASF Smart Farming’s innovative Smart Spraying Solution, which will deliver optimal herbicide savings without compromising weed control and will enable targeted spraying during day and night-time conditions. In addition to targeted spraying, the system will deliver integrated digital tools to turn the application data into actionable insights and improve yields and efficiency for farmers. Herbicide savings are delivered through sophisticated sensoring, automated sensitivity thresholds, access to Bosch BASF Smart Farming’s pest identification technology, and the use of Fendt Rogator’s robust application platform. AGCO will offer the system in the Americas and Europe starting in 2024.
Farmers will also be able to benefit from customized agronomic recommendations and reliable documentation within the same solution. The system will offer an end-to-end user experience through AGCO on-board and off-board controls and Bosch BASF Smart Farming’s integrated digital platform from xarvio® Digital Farming Solutions, with insights into the data gathered during the application.
Supported crops currently include corn, soy, cotton, canola, sunflower, and sugarbeet, with capabilities for more crops such as small grains being added over time.
“The progress we have made with Bosch BASF Smart Farming in developing a sustainable solution that maintains productivity while improving profitability and delivering clean fields with maximum savings is an excellent example of AGCO’s farmer focus,” said Seth Crawford, Senior Vice President and General Manager, Precision Ag & Digital, AGCO. “We look forward to our further collaboration with Bosch BASF Smart Farming as we work together to bring this solution to farmers and custom applicators around the world.”
“What makes our system unique is the combination of superior precision, digital tools and the agronomic expertise. With a 24/7 application capability, we create exceptional green-on-green and green-on-brown performance. This type of precision agronomics offering is a breakthrough to support farmers with less impact and higher yields,” said Matt Leininger, Managing Director North America, Bosch BASF Smart Farming.
About AGCO
AGCO (NYSE:AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers customer value through its differentiated brand portfolio including core brands like Fendt®, GSI®, Massey Ferguson®, Precision Planting® and Valtra®. Powered by Fuse® smart farming solutions, AGCO’s full line of equipment and services help farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $12.7 billion in 2022. For more information, visit www.AGCOcorp.com. For company news, information, and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
About Bosch BASF Smart Farming
Bosch BASF Smart Farming – a joint venture of Bosch and BASF – was established in 2021 to combine the best of two worlds: with the agronomic know-how from BASF and hardware expertise from Bosch, we create the farming of tomorrow, today. Combining precision technology, digital tools, and agronomic intelligence, we offer smart farming solutions that really work to make agriculture more productive, profitable, and sustainable. More information at: www.smartfarming.ag
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005041/en/
Contact information
Julie Ulbrich, AGCO | julie.ulbrich@AGCOCorp.com | +1 770-235-2943
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Experian's New Documentary RECLAIM Shows How Financial Access and Innovation Are Creating Opportunity Around the World5.11.2026 17:00:00 EET | Press release
For years, Almir dreamed of meeting his granddaughter in the United States. But unresolved debt stood in the way. Thousands of miles away in Arizona, Elizabeth faced mounting medical expenses after a health crisis. In London, Rochelle worked to regain control of her finances while caring for family members. Their stories, and others like them, are at the heart of RECLAIM: Stories of Passion and Perseverance, a new documentary from global technology and data company Experian that explores how access to financial tools, technology and support can help people overcome obstacles and pursue new opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105341861/en/ Behind-the-scenes photo from the filming of RECLAIM: Stories of Passion and Perseverance, an Experian documentary. Brody Frye, who received care from The MetroHealth System in Cleveland, Ohio, is featured in the film’s story about healthcare innovation and the p
Saudi Fund for Development Signs Six Development Loan Agreements Worth Over USD 403 Million with Syria5.11.2026 16:32:00 EET | Press release
The Saudi Fund for Development (SFD) has signed six concessional development loan agreements worth more than USD 403 million with the Syrian Arab Republic, marking a significant step in supporting the country’s recovery through the rehabilitation of essential infrastructure, restoration of vital public services and improvement of living conditions for communities affected by years of conflict. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105350224/en/ HRH the Crown Prince and President of the Syrian Arab Republic Al-Sharaa witness signing of agreements (Photo: AETOSWire The agreements, signed under the directives of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, reflect the Kingdom’s continued commitment to supporting Syria’s development priorities. The signing ceremony was witnessed by Hi
LPs Expect Private Markets Managers to Level Up in 2027: SS&C Intralinks Survey5.11.2026 16:00:00 EET | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the publication of the 2027 LP Survey. In association with Reuters Insights, SS&C Intralinks surveyed 400 professionals working in private markets, including 370 limited partners and allocators, to understand how the alternative investments market will change in the next 12 months.* “Alternatives once again delivered in 2026, and LPs are still committing capital, but their expectations of managers continue to rise,” said Ken Bisconti, general manager of SS&C Intralinks. “Technology and data capabilities now rank among the most important criteria for selecting managers, alongside investment strategy. Performance alone is no longer enough. For nearly one-third of allocators, a credible artificial intelligence (AI) strategy is now a prerequisite for allocating capital to a manager.” Key findings from the report include: Alternatives portfolios continue to outperform. 62% of respondents said their portfolios exceeded expectati
Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design5.11.2026 16:00:00 EET | Press release
Hyperice, a high-performance wellness brand, today announced the launch of Normatec Elite Heat Legs, the newest innovation in the award-winning Normatec line and the first Normatec product to incorporate heat directly into its line of dynamic air compression therapy. As the 2024 launch of Normatec Elite signified a transformative leap forward in recovery technology, Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105782891/en/ Normatec Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. “Innovation has always been at the forefront of everything we do,” said Jim Huether, CEO of Hyperice. “Heat and dynamic air compressio
European Commission expands license for Alfasigma’s Jyseleca ® (filgotinib) with approval of new indication, treatment of adults with axial spondylarthritis5.11.2026 16:00:00 EET | Press release
The information contained within this press release is for the purpose of scientific exchange. It is intended for scientific, financial and investor media only. Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Commission (EC) has approved an additional indication to Jyseleca® (filgotinib) 200 mg and 100 mg film-coated tablets, an oral once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. A submission for UK approval has been made to the Medicines and Healthcare products Regulatory Agency (MHRA) and is under review. The European Commission’s approval is based on data that support a favourable benefit-risk profile for filgotinib, including efficacy and safety fin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom